Pluristem Therapeutics Inc. (PSTI) stock is higher by 75.09% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PSTI stock a score of 79 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 100. PSTI's rank also includes a long-term technical score of 100. The fundamental score for PSTI is 38. In addition to the average rating from Wall Street analysts, PSTI stock has a mean target price of 15.125. This means analysts expect the stock to climb 51.55% over the next 12 months.
What's Happening with PSTI Stock Today
Pluristem Therapeutics Inc. (PSTI) stock is higher by 1.38% while the S&P 500 is higher by 0.43% as of 11:30 AM on Thursday, Apr 16. PSTI is higher by $0.14 from the previous closing price of $9.84 on volume of 3,135,382 shares. Over the past year the S&P 500 has fallen -3.62% while PSTI is higher by 75.09%. PSTI lost -$8.02 per share in the over the last 12 months.